Stockreport

Olema Oncology to Present at 43rd Annual J.P. Morgan Healthcare Conference

Olema Pharmaceuticals, Inc.  (OLMA) 
PDF SAN FRANCISCO, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company fo [Read more]